Skip to content

Clinical trials

Seizures trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Country / region: South Korea Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20061
20071
20081
20101
20111
20122
20132
20141
20161
20171
20181
20202
20213
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.6
SK Life Science, Inc.5
AbbVie2
GlaxoSmithKline2
Astellas Pharma Global Development, Inc.1
Eisai Co., Ltd.1
Eisai Inc.1
Eisai Korea Inc.1
Gil Joon Suh1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures27
Epilepsy13
Epilepsies, Partial9
Epilepsy, Complex Partial1
Epilepsy, Tonic-Clonic1
Heart Arrest1
Hemorrhage1
Lennox Gastaut Syndrome1
Liver Neoplasms1
Prostatic Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.